Skip to main content
Top
Published in: Obesity Surgery 11/2019

01-11-2019 | Obesity | Original Contributions

Metabolic Syndrome Rather than Obesity Alone Is More Significant for Kidney Disease

Authors: Samir I. Bagasrawala, Harsh Sheth, Hemal Shah, Rais Ansari, Muffazal Lakdawala

Published in: Obesity Surgery | Issue 11/2019

Login to get access

Abstract

Introduction

Obesity is associated with metabolic syndrome, nonalcoholic steatohepatitis, and kidney disease. BMI may not be the ideal measure of obesity when used to assess its effect on kidney disease as it does not discriminate for age, sex, ethnicity, muscle, bone, or fat mass.

Objectives

To assess the prevalence microalbuminuria and identify independent risk factors for development of kidney disease in the obese Indian population.

Methods

Age, weight, BMI, total body fat percentage, waist-to-hip ratio, hypertension, urinary albumin-to-creatinine ratio (UACR), and HbA1c were collected from 568 obese patients, presenting for bariatric surgery. Multivariate binary logistic regression was used to identify independent risk factors for kidney disease.

Results

A total of 114 out of 568 (20.07%) obese patients had microalbuminuria (UACR range 30–283 μg/mg). HbA1C levels ≥ 6 (p = 0.01) and hypertension (p = 0.03) were the strongest independent variables for microalbuminuria. 14.67% with a BMI < 35 kg/m2, 21.30% with a BMI 35–50 kg/m2, and 19.44% with a BMI > 50 kg/m2 had microalbuminuria. Increasing BMI however was not statistically significant (p = 0.75). Total body fat percentage (p = 0.51), waist-to-hip ratio (p = 0.96), age (p = 0.30), sex (p = 0.38), and BMI (p = 0.75) were found to be statistically insignificant.

Conclusions

Kidney disease afflicts 1/5th of the obese Indian patients studied. Diabetes and hypertension remained as the most significant risk factors, while age, weight, increasing BMI, waist-to-hip ratio, or increasing body fat were found to be statistically insignificant for development and progression of kidney disease.
Literature
1.
go back to reference Geneva: WHO. [accessed on November 28, 2012]. World Health Organization (WHO). 2012. World health statistics 2012. Geneva: WHO. [accessed on November 28, 2012]. World Health Organization (WHO). 2012. World health statistics 2012.
2.
go back to reference Rutkowski P, Klassen A, Sebekova K, et al. Renal disease in obesity: the need for greater attention. J Ren Nutr. 2006;16(3):216–23.CrossRefPubMed Rutkowski P, Klassen A, Sebekova K, et al. Renal disease in obesity: the need for greater attention. J Ren Nutr. 2006;16(3):216–23.CrossRefPubMed
3.
go back to reference Wiggins KJ, Johnson DW. The influence of obesity on the development and survival outcomes of chronic kidney disease. Adv Chronic Kidney Dis. 2005;12(1):49–55.CrossRefPubMed Wiggins KJ, Johnson DW. The influence of obesity on the development and survival outcomes of chronic kidney disease. Adv Chronic Kidney Dis. 2005;12(1):49–55.CrossRefPubMed
4.
go back to reference Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–7.CrossRefPubMed Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–7.CrossRefPubMed
5.
go back to reference Gerstein HC, Mann JFE, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study. Diabetes Care. 2000;23(supplement 2):B35–9.PubMed Gerstein HC, Mann JFE, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study. Diabetes Care. 2000;23(supplement 2):B35–9.PubMed
6.
go back to reference Cao JJ, Barzilay JI, Peterson D, et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health study. Atherosclerosis. 2006;187(2):372–7.CrossRefPubMed Cao JJ, Barzilay JI, Peterson D, et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health study. Atherosclerosis. 2006;187(2):372–7.CrossRefPubMed
7.
go back to reference Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens. 2006;15(5):481–6.CrossRefPubMed Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens. 2006;15(5):481–6.CrossRefPubMed
8.
go back to reference Chen H-M, Liu Z-H, Zeng C-H, et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis. 2006;48(5):772–9.CrossRefPubMed Chen H-M, Liu Z-H, Zeng C-H, et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis. 2006;48(5):772–9.CrossRefPubMed
9.
go back to reference Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006;26(3):232–44.CrossRefPubMed Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006;26(3):232–44.CrossRefPubMed
10.
go back to reference Agrawal V, Shah A, Rice C, et al. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol. 2009;5(9):520–8.CrossRefPubMed Agrawal V, Shah A, Rice C, et al. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol. 2009;5(9):520–8.CrossRefPubMed
11.
go back to reference Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–71.CrossRefPubMed Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–71.CrossRefPubMed
12.
go back to reference Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. JASN. 2010;21(3):406–12.CrossRefPubMed Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. JASN. 2010;21(3):406–12.CrossRefPubMed
13.
go back to reference Yano Y, Hoshide S, Ishikawa J, et al. (2007) Differential impacts of adiponectin on low- grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens (Greenwich) 9(10):775–782. [Epub 2007/10/06]CrossRefPubMed Yano Y, Hoshide S, Ishikawa J, et al. (2007) Differential impacts of adiponectin on low- grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens (Greenwich) 9(10):775–782. [Epub 2007/10/06]CrossRefPubMed
14.
go back to reference Cannon CP, Kumar A. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clin Cornerstone. 2009;9(4):55–68. (discussion 9–71)CrossRefPubMed Cannon CP, Kumar A. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clin Cornerstone. 2009;9(4):55–68. (discussion 9–71)CrossRefPubMed
15.
go back to reference McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382–6.CrossRefPubMed McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382–6.CrossRefPubMed
16.
go back to reference Raji A, Seely EW, Arky RA, et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86:5366–71.CrossRefPubMed Raji A, Seely EW, Arky RA, et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86:5366–71.CrossRefPubMed
17.
go back to reference Chandie Shaw PK, Baboe F, van Es LA, et al. South Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch European diabetic patients. Diabetes Care. 2006;29:1383–5.CrossRefPubMed Chandie Shaw PK, Baboe F, van Es LA, et al. South Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch European diabetic patients. Diabetes Care. 2006;29:1383–5.CrossRefPubMed
18.
go back to reference Herrera-Valdes R, Almaguer M, Chipi J, et al. Prevalence of obesity and its associ- ation with chronic kidney disease, hypertension and diabetes mellitus. Isle of Youth Study (ISYS), Cuba. MEDICC Rev. 2008;10(2):14–20.PubMed Herrera-Valdes R, Almaguer M, Chipi J, et al. Prevalence of obesity and its associ- ation with chronic kidney disease, hypertension and diabetes mellitus. Isle of Youth Study (ISYS), Cuba. MEDICC Rev. 2008;10(2):14–20.PubMed
19.
go back to reference KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–154. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–154.
20.
go back to reference World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253 World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253
21.
go back to reference Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR study. J Hypertens. 2006;24:1157–63.CrossRefPubMed Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR study. J Hypertens. 2006;24:1157–63.CrossRefPubMed
22.
go back to reference Chen F, Yang W, Weng J, et al. Albuminuria: prevalence, associated risk factors and relationship with cardiovascular disease. J Diabetes Investig. 2014;5(4):464–71.CrossRefPubMed Chen F, Yang W, Weng J, et al. Albuminuria: prevalence, associated risk factors and relationship with cardiovascular disease. J Diabetes Investig. 2014;5(4):464–71.CrossRefPubMed
24.
go back to reference Afkhami-Ardekani M, Modarresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008;18(3):112–7.CrossRefPubMedPubMedCentral Afkhami-Ardekani M, Modarresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008;18(3):112–7.CrossRefPubMedPubMedCentral
26.
go back to reference Atta MI, Abdalla NH, Ibrahim AA. Microalbuminuria and adiponectin in obese nondiabetic nonhypertensive people. Egypt J Obes Diabetes Endocrinol 2016;2:156–62CrossRef Atta MI, Abdalla NH, Ibrahim AA. Microalbuminuria and adiponectin in obese nondiabetic nonhypertensive people. Egypt J Obes Diabetes Endocrinol 2016;2:156–62CrossRef
27.
go back to reference Ferris M. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol. 2007;2(6):1207–14.CrossRefPubMed Ferris M. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol. 2007;2(6):1207–14.CrossRefPubMed
28.
go back to reference Kenealy T, Elley CR, Collins JF, et al. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant. 2012;27(5):1840–6.CrossRefPubMed Kenealy T, Elley CR, Collins JF, et al. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant. 2012;27(5):1840–6.CrossRefPubMed
Metadata
Title
Metabolic Syndrome Rather than Obesity Alone Is More Significant for Kidney Disease
Authors
Samir I. Bagasrawala
Harsh Sheth
Hemal Shah
Rais Ansari
Muffazal Lakdawala
Publication date
01-11-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 11/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04011-2

Other articles of this Issue 11/2019

Obesity Surgery 11/2019 Go to the issue